Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Aug;17(2):430-8.
doi: 10.1128/iai.17.2.430-438.1977.

Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition

Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition

I A Clark et al. Infect Immun. 1977 Aug.

Abstract

Infection of mice with Bacillus Calmette-Guérin (BCG) provided good protection against Babesia species. The intensity and duration of this protection was similar to that established after natural recovery from babesiosis. It developed too soon after the first exposure to the parasite, and was too radioresistant, to be attributable to specific antibody production. In addition, the parasites degenerated within circulating erythrocytes. This phenomenon is inconsistent with phagocytosis or lysis of parasites or parasitized cells, or prevention of entry of parasites into erythrocytes, causing the observed protection. Hence the phenomenon is best explained by the release of a nonspecific mediator that can limit multiplication of parasites within erythrocytes. These results not only throw light on mechanisms of immunity against hemoprotozoa. There are many points of similarity between the nonspecific protection BCG and Corynebactium parvum provide against Babesia species and inhibition of tumor growth by these agents. Therefore, babesiosis in mice may be a convenient experimental model for assessing stimulation of the mononuclear phagocyte system, which appears to be the basis of nonspecific immunity against bacteria, parasites, and tumors.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666-70 - PubMed
    1. Am J Ophthalmol. 1975 Apr;79(4):641-7 - PubMed
    1. J Natl Cancer Inst. 1975 Nov;55(5):1233-6 - PubMed
    1. J Natl Cancer Inst. 1976 Jan;56(1):153-7 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1973 Aug 31;184(1074):97-102 - PubMed

LinkOut - more resources